Wayfinder Biosciences
Unlocking the future of smart biotechnology
* Data source: Crunchbase
- Founded
- 2021
- Employees*
- 2-10
- Funding to Date*
- $6,800,000
- Website
- wayfinderbio.com
“Many key drivers of disease remain impossible or extremely challenging to drug today. By targeting at the RNA level, we can prevent disease-proteins from being made in the first place.”
It takes the world's RNA experts years to make an RNA-based biosensor. Wayfinder does it in 2 weeks.
Wayfinder is using computational design to program RNA logic themselves, specifically controlling how cells respond on demand using the molecules they choose. Wayfinder is unlocking the future of biomanufacturing with nano-scale sensors that light up to discover cells thousands of times faster than biotech’s billion-dollar companies. What comes next is the future of everything else, from smart mRNA vaccines and smart cell factories to smart CRISPR.
More Companies
